<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药明康德 | wechat-feeds</title><link>http://MzAwMDA5NTIxNQ.favicon.privacyhide.com/favicon.ico</link><description>全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台，帮助任何人、任何公司更快、更好地研发新医药产品，探索无限可能</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 02 Feb 2021 20:45:04 +0800</pubDate><image><url>http://MzAwMDA5NTIxNQ.favicon.privacyhide.com/favicon.ico</url><title>药明康德 | wechat-feeds</title><link>http://MzAwMDA5NTIxNQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>合全药业宣布收购百时美施贵宝瑞士库威（Couvet）生产基地 | Bilingual News</title><link>https://mp.weixin.qq.com/s/7BqlVAajHr6RxZE9eQVHIA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gMzIbO69TOT9O8Mv6cDIxjFSXqyHmQpd4iaS9KOibicWIBMcicgdIneIzHAlH1SWmHXUKBZyh2zSXdXgg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>WuXi STA to Purchase Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland]]></content:encoded><pubDate>Tue, 02 Feb 2021 19:54:38 +0800</pubDate></item><item><title>抗击衰老与神经系统疾病：只差临门一脚？ | 药明康德全球论坛实录</title><link>https://mp.weixin.qq.com/s/1jLxKb5lKO2BvnOQiYzDQg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gPuEyOjnm1gvMqozaj4NndsunenmQhQh1lnMvDc3FibicZy1JhtNEmb9pEBlmhy3NGvjiaOWXKcdng9Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>要在出现症状前进行治疗]]></content:encoded><pubDate>Tue, 02 Feb 2021 19:54:38 +0800</pubDate></item><item><title>速递 | 约30亿美元囊获自身免疫性疾病药物管线，Horizon拟收购Viela Bio</title><link>https://mp.weixin.qq.com/s/_l-fuFtyP_XWaHf1gUVZtQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gPuEyOjnm1gvMqozaj4NndsHXbUFUOSvRF5WfibbqWWhFicoIfWhPgxzD6T0jmibKpgvU2ibgSnM6aPXQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>包括已获批的抗CD19抗体疗法]]></content:encoded><pubDate>Tue, 02 Feb 2021 19:54:38 +0800</pubDate></item><item><title>速递 | 7.85亿美元打造HIV治愈性疗法，吉利德科学达成合作</title><link>https://mp.weixin.qq.com/s/CF01yQeve1Wp3vi9oC5YBw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gPuEyOjnm1gvMqozaj4NndsO5b8OarYj3unrkN3fALP6icNuH3F7tLiadibYBqbozG2TJmOReEOu7icgQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>创新疫苗平台激发强力CD8阳性T细胞反应]]></content:encoded><pubDate>Tue, 02 Feb 2021 19:54:38 +0800</pubDate></item><item><title>速递 | 美国FDA批准帕金森病新药扩展适应症，可同时治疗“关闭期”和运动障碍</title><link>https://mp.weixin.qq.com/s/SjzdgmQDTMyVMN4j6jr_6Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gPuEyOjnm1gvMqozaj4NndsurPUYk9EpFQZRV60fuBfwPlpdoxSpqGPm0Mg8kPsXeoyqllxRZIpnA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>目前首款获批同时治疗运动障碍和“关闭期”的帕金森病疗法。]]></content:encoded><pubDate>Tue, 02 Feb 2021 19:54:38 +0800</pubDate></item><item><title>速递 | 有望成为首个治疗溃疡性结肠炎的S1P受体调节剂，BMS创新疗法获FDA优先审评资格</title><link>https://mp.weixin.qq.com/s/dUJsGULc490hYeGmvO_qCA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gPuEyOjnm1gvMqozaj4NndsT90JFicUriaoia2mwfCU9dpxQLJ7tcrkAFwRh8kFvGgPOIZI6MR1yZXMw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>已经获批治疗多发性硬化]]></content:encoded><pubDate>Tue, 02 Feb 2021 19:54:38 +0800</pubDate></item><item><title>速递 | 潜在“best-in-class”外用PDE4抑制剂达到3期临床终点，治疗斑块状银屑病</title><link>https://mp.weixin.qq.com/s/i1IjhWbvv4jiobsmtyHJXg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gPuEyOjnm1gvMqozaj4NndskG2GjibwwEcspavQWE67RAPyJt3hKyee5yKiaQNr3LpKwfxIJp6iabyeQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>今年下半年递交新药申请]]></content:encoded><pubDate>Tue, 02 Feb 2021 19:54:38 +0800</pubDate></item><item><title>逃得过中和抗体，逃不过T细胞，免疫系统识别新冠突变病毒的“双保险”</title><link>https://mp.weixin.qq.com/s/-9glEIS4jqWSgkMtJtphFg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNtfDEOlcw52dn4pGPSuzwOkUiaX2bECzA4eQOBuv9KwsLTsPdN577V70qKMeyKp9nYqGyQO2cGnxA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药明康德]]></content:encoded><pubDate>Mon, 01 Feb 2021 07:32:38 +0800</pubDate></item><item><title>癌症攻坚20年：下一个突破在何方？| 药明康德全球论坛实录</title><link>https://mp.weixin.qq.com/s/3ImkkNsdqvlDjyhAMFX7jQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gOicRsJXbxYOGmFYJRvs1D9OMeyvibh6ibAoH4F4V2NEticp7RoTOa5P6sA2gOTWp3OOia58mYYicvX2NCQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>对话阿斯利康肿瘤治疗领域研发总裁]]></content:encoded><pubDate>Mon, 01 Feb 2021 07:32:38 +0800</pubDate></item><item><title>礼来、GSK、Vir合作开发中和抗体组合疗法；FDA批准首款口服狼疮性肾炎创新疗法</title><link>https://mp.weixin.qq.com/s/y_5Lzs7oTXQxreoo7DJ23w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNtfDEOlcw52dn4pGPSuzwOAQ8iaMlKyyNEviazaWic5nX5p8ibr7ulyibiaiaibicrFjHN4ibCmS9HhukPhmBg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>一周新闻盘点]]></content:encoded><pubDate>Mon, 01 Feb 2021 07:32:38 +0800</pubDate></item><item><title>孤儿药周报 | 创新免疫激活细胞、安进重组蛋白等8款疗法入围</title><link>https://mp.weixin.qq.com/s/SEjvcF084GhMWP4nrIAFWA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNtfDEOlcw52dn4pGPSuzwOrx56zvzUPgngcoSZMXYiaJLcA4zLY1YzrWJBOTuM2hjzxVicDlO81g1Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药明康德]]></content:encoded><pubDate>Mon, 01 Feb 2021 07:32:38 +0800</pubDate></item><item><title>睡个好觉太重要了！科学家揭示深度睡眠加快大脑“排毒”</title><link>https://mp.weixin.qq.com/s/7tPIYrMp7TtBlYlR_kXl2Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/UdvecgtVRYK0sV7mMiaJbqrXuTJP1ibYAywyib4x52ic6Mf7LBKw9U6jPsbNhMtKPX1TYKnNiaJZiaMC16YSCsDveoZg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>深度睡眠的古老功能]]></content:encoded><pubDate>Mon, 01 Feb 2021 07:32:38 +0800</pubDate></item><item><title>《柳叶刀》：减少一半死亡！98国数据揭示10种常见疫苗的深远影响</title><link>https://mp.weixin.qq.com/s/ALlyQVkVyhSsvkdEEViVcQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/EIicaxb3hLFUiaR9HDIcxfrr3daF4a4j7ibhibcC4icyuhtNWX8uAnGG5TegWj7DS7j9zAXiaiaTrjRPzW4qeAUJ71deA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>应当“确保每个人一生中都按时接种所有疫苗”]]></content:encoded><pubDate>Mon, 01 Feb 2021 07:32:38 +0800</pubDate></item><item><title>强生单剂新冠疫苗达到3期临床主要终点，下周递交EUA申请</title><link>https://mp.weixin.qq.com/s/CYqc3nt1yBeEPDQb-Ww4uQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNibwc8hIwdVWkQzibic29M5um4H79K9xw4B0kibbL8oFRibppLnBNAbhpd8xCWlDc1VFNxNmHiazMAJtYg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药明康德]]></content:encoded><pubDate>Sat, 30 Jan 2021 07:53:46 +0800</pubDate></item><item><title>罕见病专栏 | 一周罕闻药事（1.23-1.29）</title><link>https://mp.weixin.qq.com/s/-q8Sx5d-JFXlLFh28V0ynQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNDMeJZiaFaqUv0lLceQMa9ty1gibZQWibPicficre59nB0wZjJib5kdHo18yicQHGq9Se99gJ6KCvafYW2A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>罕闻药事，为您汇总罕见病研发领域最新资讯]]></content:encoded><pubDate>Sat, 30 Jan 2021 07:53:46 +0800</pubDate></item><item><title>89.3％防护效力，Novavax公布新冠疫苗英国3期临床试验结果</title><link>https://mp.weixin.qq.com/s/E0Xt6DVp5Z7whzGheVkERw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNibwc8hIwdVWkQzibic29M5umJ37IPwiblqkULLWXKYjxDticujxPAcUbXONoXtIK3j5KCianIF7XciaR8Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>南非出现的新冠病毒突变株对保护能力产生影响]]></content:encoded><pubDate>Sat, 30 Jan 2021 07:53:46 +0800</pubDate></item><item><title>速递 | 治疗非小细胞肺癌，TROP2靶向ADC临床结果积极</title><link>https://mp.weixin.qq.com/s/CkrVYmEZThBLDYziPXnc0Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNibwc8hIwdVWkQzibic29M5umT5bn6H9L0eG6XEo0wB10VQcODVz2NmWv7YJhRw8Dnz2Lo0icW0lxR9w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>“具有变革晚期肺癌靶向治疗的潜力”]]></content:encoded><pubDate>Sat, 30 Jan 2021 07:53:46 +0800</pubDate></item><item><title>疾病控制率达74%，杨森EGFR/MET双特异性抗体治疗特定非小细胞肺癌结果积极</title><link>https://mp.weixin.qq.com/s/kAUddl5XTywF7E6IDVKiLQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNibwc8hIwdVWkQzibic29M5um9OnuczxGU4hLjBhuog9DHQabmObNBTlGEsicponOicG9WwhStzGPOZxg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>已经向FDA递交新药申请]]></content:encoded><pubDate>Sat, 30 Jan 2021 07:53:46 +0800</pubDate></item><item><title>《自然》子刊综述：乳腺癌的治疗现状与未来</title><link>https://mp.weixin.qq.com/s/xo8RXqTAzFnt-wYB27RtDw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gM8sB7qr4m4ljTxiaByW2YqLNrBr9cO9e9O1Ikvj7jYASXDT8iaJeTNKmJ8Nu7OiatOiagGDyLxeRxNoQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2020年全球新发乳腺癌达到226万例，首次超过肺癌（221万例）成为全球第一大癌症。]]></content:encoded><pubDate>Fri, 29 Jan 2021 08:09:49 +0800</pubDate></item><item><title>如何从“偶尔治愈”迈向“经常治愈”？ | 药明康德全球论坛实录</title><link>https://mp.weixin.qq.com/s/xWSKAuaszgLtz_wTea0u3A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gM8sB7qr4m4ljTxiaByW2YqLPtoYtoIMmTFxelOdXudayN3oeibJaKyFZRcYIuGsmCdSicX6fR8miawAQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>来自著名投资人Robert Nelsen先生的见解]]></content:encoded><pubDate>Fri, 29 Jan 2021 08:09:49 +0800</pubDate></item></channel></rss>